0001494650-23-000089.txt : 20230919
0001494650-23-000089.hdr.sgml : 20230919
20230919190436
ACCESSION NUMBER: 0001494650-23-000089
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230915
FILED AS OF DATE: 20230919
DATE AS OF CHANGE: 20230919
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Marino Michael F III
CENTRAL INDEX KEY: 0001502700
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38241
FILM NUMBER: 231265034
MAIL ADDRESS:
STREET 1: C/O NUPATHE, INC.
STREET 2: 227 WASHINGTON STREET, SUITE 200
CITY: CONSHOHOCKEN
STATE: PA
ZIP: 19428
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OptiNose, Inc.
CENTRAL INDEX KEY: 0001494650
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 421771610
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1020 STONY HILL ROAD
STREET 2: SUITE 300
CITY: YARDLEY
STATE: PA
ZIP: 19067
BUSINESS PHONE: 267-364-3500
MAIL ADDRESS:
STREET 1: 1020 STONY HILL ROAD
STREET 2: SUITE 300
CITY: YARDLEY
STATE: PA
ZIP: 19067
4
1
wk-form4_1695164668.xml
FORM 4
X0508
4
2023-09-15
0
0001494650
OptiNose, Inc.
OPTN
0001502700
Marino Michael F III
C/O OPTINOSE, INC.
1020 STONY HILL ROAD, SUITE 300
YARDLEY
PA
19067
0
1
0
0
Chief Legal Officer & Corp Sec
0
Common Stock
2023-09-15
4
A
0
3817
0
A
339690
D
Common Stock
2023-09-18
4
S
0
4991
1.37
D
334699
D
Represents the vesting of performance-based restricted stock units (Performance RSUs) granted on March 6, 2020. Fifty percent (50%) of the Performance RSUs vested on June 15, 2022, upon achievement of certain milestones in connection with the Company's development programs. The balance vests in eight equal quarterly installments, subject to continued service with the Issuer. Each Performance RSU represents the right to receive one share of common stock of OptiNose, Inc.
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units under multiple award agreements. This sale is mandated by the issuer's award agreement under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
/s/ Anthony Krick, Attorney-in-Fact
2023-09-19